Life Science Technical Accounting Update 2025

From Gross to Net Estimates and Accruals to Preparing for an IPO to Government Pricing for Biotechs to Revenue Recognition examples and latest updates, this conference will address the latest developments in key areas. You'll hear from experts at Deloitte, Ernst and Young, Effectus Group, life science analysts and your industry counterparts. LEARNING OBJECTIVES: Understand the latest accounting changes in key areas Recognize the timelines and key factors affecting the life science industry Begin to assess the effects of these standards on your company or clients REGISTRATION INFORMATION:  1. Register online using a credit card and click the orange button 2. Register by phone at (610) 789-3110 3. Email your contact info to be invoiced to Edit Agenda: DAY 1 8:45 10:10 Recent Accounting Trends in the Life Science Industry Collaboration Accounting Grants Inbound Licenses Accounting for Financing Arrangements 10:10 10:20 Break 10:20 11:30 Tax Update Latest legislative developments Key Tax Proposals Build Back Better Act Observations Possible timing and other legislative priorities 11:30 12:15 Lunch Break 12:15 1:35 Revenue Recognition: Evolving Issues - Life Sciences Scope of Contract Performance Obligations Nature of promise: sales of points Collaboration agreements Sales using third party platforms Gross vs Net Counterparty Perspective\ 1:35 1:50 Break 1:50 3:15 Regulatory Update Cybersecurity Risk Management, Strategy Governance and Incident Disclosure Market Trends SEC Requirements Explained The Framework Disclosure Examples Financial Accounting Update FASB Project Update ASUs Issues on the horizon 3:15 3:25 Break 3:25 4:45 SOX and Internal Controls Update Risk Assesment Management Review Controls Information Used in Controls IT - General Controls Considerations Edit Agenda: DAY 2 8:45 10:00 GenAI Use Cases in Accounting and Finance Examine risks and myths Explore AI use cases Define steps for adopting AI Practical use cases for today Exciting use cases for tomorrow 10:00 10:15 Break 10:15 11:45 Gross to Net Introduction and Overview Industry View Estimation Methodology Approaching Launch Key Challenges SEC Comments Close and Financial Reporting GTN Hot Topics Discussion Inventory Accounting Refresh 11:45 12:20 Lunch Break 12:20 1:40 Financing Trends Royalty Monetization Convertible Debt Accounting Considerations When should companies consider convertible debt? Convertible structure in the life science financing cycle Changes of control, tax implications, size, maturity and other questions 1:40 1:50 Break 1:50 3:10 Accounting for R and D and Clinical Trials R and D Funding Arrangements R and D Cost Classifications Other Intangible Assets SEC Comment Letter Trends 3:10 3:20 Break 3:20 4:40 ESG ESG Landscape: Regulatory Developments Operationalizing ESG and Sustainability Disclosure Trends in Life Sciences Industry Taking Action